- Tytuł:
- Age is a significant biomarker for the selection of neoadjuvant chemotherapy plus radiotherapy versus concurrent chemoradiotherapy in patients with advanced nasopharyngeal carcinoma.
- Autorzy:
- Źródło:
- Cancer Biomarkers. 2023, Vol. 37 Issue 1, p1-11. 11p.
Czasopismo naukowe